SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: 777 Captain who wrote (22492)9/14/1999 11:49:00 PM
From: Patscara  Respond to of 23519
 
1.Muse Script numbers would be nice.
Germany, England,& Sweden?

2. When they plan to launch the other EU countries?

You were probably going to ask them anyway! Right!

Thanks, Pat



To: 777 Captain who wrote (22492)9/15/1999 4:38:00 AM
From: wvalx  Read Replies (1) | Respond to of 23519
 
- Are they still fully committed to MUSE in lieu of Viagra?
- Are they interested in pursuing Alibra marketing rights?
- How would they characterize their relationship with Vivus?
- Obviously, how are the Germany sales going?
- Why do they feel it necessary to launch Spain, Italy and France all at once, instead of one at a time?
- Are they launching the rest of the EU countries before Spain, Italy, and France?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News